Tokyo, Jan. 15 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000060313) titled 'Clinical results of zoledronic acid in the treatment of osteoporosis' on Jan. 15.
Study Type:
Observational
Primary Sponsor:
Institute - Niimi orthopaedics clinic
Condition:
Condition - Osteoporosis
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To clarify the treatment outcomes of twice-weekly injections of zoledronic acid in real-world clinical practice.
Basic objectives2 - Safety,Efficacy
Eligibility:
Age-lower limit - 30
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - Osteoporosis
Key exclusion criteria - Patie...